Targeted News Service (Press Releases) May 16,
2018
WASHINGTON, May 15 -- The U.S. Department of Health and
Human Services' Centers for Medicare and Medicaid Services issued the following
news release:
Today, the Centers for Medicare & Medicaid Services
(CMS) released a redesigned version of the Drug Spending Dashboards. For the
first time, the dashboards include year-over-year information on drug pricing
and highlight which manufactures have been increasing their prices.
"Under President Trump's bold leadership, CMS is
committed to putting patients first and increasing transparency," said CMS
Administrator Seema Verma. "Publishing how much individual drugs cost from
one year to the next will provide much-needed clarity and will empower patients
and doctors with the information they need. As Secretary Azar has repeatedly
pointed out, for years Medicare incentives have actually encouraged higher list
prices for drugs, and this updated and enhanced dashboard is an important step
to bringing transparency and accountability to what has been a largely hidden
process."
The dashboards are interactive online tools that allow
patients, clinicians, researchers, and the public to understand trends in drug
spending. Data is reported for both Medicare and Medicaid. The new version of
the dashboard reports the percentage change in spending on drugs per dosage
unit and includes an expanded list of drugs.
Some of the most commonly used drugs across Medicare Part
B, Medicare Part D, and Medicaid saw double-digit annual increases over the
last few years. A few examples are highlighted in the tables below. Taking the
15 drugs with the highest total spending in each program, the drugs listed in
the tables saw significant annual increases in spending per dosage unit from
2012 to 2016. Drugs were included if they experienced annual increases of at
least 5 percent in Part B and at least 10 percent in Part D and Medicaid.
In 2012, Medicare spent 17 percent of its total budget, or
$109 billion, on prescription drugs. Four years later in 2016, spending had
increased to 23 percent, or $174 billion. In 2016, the drugs listed below
accounted for $39 billion in total spending by Medicare and Medicaid.
Also, as part of
CMS's commitment to transparency and data release, CMS today is updating the
Part D Prescriber Public Use File (PUF) with data for 2016. This file includes
summarized information on the more than one million distinct health care
providers who prescribed drugs under the Part D program in 2016. This
information enables a range of analyses to be performed on prescribing trends
in Part D. The Part D Prescriber PUF is available at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Medicare-Provider-Charge-Data/Part-D-Prescriber.html.
In all of CMS's
efforts, CMS protects the privacy and security of healthcare data. None of
today's releases include any patient-identifiable data. The dashboards and a
downloadable, machine-readable version of the data presented in the dashboards
can be accessed at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Information-on-Prescription-Drugs/index.html.
To View the Table
Click Here: https://www.cms.gov/Newsroom/MediaReleaseDatabase/Press-releases/2018-Press-releases-items/2018-05-15.html
No comments:
Post a Comment